SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote, Steven Joniau, Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?, BJU International, 2015, 115, 3
  2. 2
    Maria E. Suarez-Almazor, Prashanth Peddi, Ruili Luo, Hoang T. Nguyen, Linda S. Elting, Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy, Supportive Care in Cancer, 2014, 22, 2, 537

    CrossRef

  3. 3
    Benjamin A. Gartrell, Fred Saad, Managing bone metastases and reducing skeletal related events in prostate cancer, Nature Reviews Clinical Oncology, 2014, 11, 6, 335

    CrossRef

  4. 4
    A. S. Cheung, J. D. Zajac, M. Grossmann, Muscle and bone effects of androgen deprivation therapy: current and emerging therapies, Endocrine Related Cancer, 2014, 21, 5, R371

    CrossRef

  5. 5
    Nichole Korpi-Steiner, Denise Milhorn, Catherine Hammett-Stabler, Osteoporosis in men, Clinical Biochemistry, 2014, 47, 10-11, 950

    CrossRef

  6. 6
    Connie Limburg, Cathy Maxwell, Beatrice Mautner, Prevention and Treatment of Bone Loss in Patients With Nonmetastatic Breast or Prostate Cancer Who Receive Hormonal Ablation Therapy, Clinical Journal of Oncology Nursing, 2014, 18, 2, 223

    CrossRef

  7. You have free access to this content7
    Jennifer L. Beebe-Dimmer, Stephen J. Freedland, Androgen deprivation therapy: further confirmation of known harms, BJU International, 2013, 111, 5
  8. 8
    Mathis Grossmann, Ada S. Cheung, Jeffrey D. Zajac, Androgens and prostate cancer; pathogenesis and deprivation therapy, Best Practice & Research Clinical Endocrinology & Metabolism, 2013, 27, 4, 603

    CrossRef

  9. 9
    A. S. Cheung, D. Pattison, I. Bretherton, R. Hoermann, D. Lim Joon, E. Ho, T. Jenkins, E. J. Hamilton, K. Bate, I. Chan, J. D. Zajac, M. Grossmann, Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines, Andrology, 2013, 1, 4
  10. 10
    Jennifer Rothschild, Ian M. Thompson, Raoul S. Concepcion, Neal D. Shore, Infusion Therapy and Implantables for the Urologist, Urologic Clinics of North America, 2013, 40, 4, 591

    CrossRef

  11. 11
    Karynsa Cetin, Shuling Li, Anne H. Blaes, Scott Stryker, Alexander Liede, Thomas J. Arneson, Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States, Urology, 2013, 81, 6, 1184

    CrossRef

  12. 12
    Liam Bourke, Dianna Smith, Liz Steed, Richard Hooper, James Catto, Peter C Albertsen, Bertrand Tombal, Heather A Payne, Derek J Rosario, Exercise interventions for men with prostate cancer, The Cochrane Library,